The Department of Defense (DOD) Pharmacy and Therapeutics (P&T) Committee (henceforth, P&T Committee) is responsible for development and maintenance of the TRICARE Uniform Formulary that is based on clinically appropriate, cost-effective, and rational therapy recommendations. This charter outlines the roles and responsibilities of the DOD P&T Committee.

This memorandum provides objective criteria that military medical treatment facilities should consider in referral management to assess and treat ocular injuries in the Military Health System.

This memorandum provides supplemental guidance on the provision of care for individuals diagnosed with gender dysphoria (GD) within the Military Health System's direct care component and through the Supplemental Health Care Program.

The Military Health System Staffing Transparency and Resourcing Impact Business Rules establish a collaborative process between the Military Services and the Defense Health Agency (DHA) for providing transparent information on the assignment and availability of uniformed medical and dental personnel, civilian employee, and contractor personnel to ...

This document details the guiding principles, responsibilities, and processes for conducting Human Capital Distribution in the Military Health System. The MHS Human Capital Distribution Plan business rules establish a collaborative process between the Military Departments and the Defense Health Agency for planning and programming the uniformed medical ...

Military Health System notification business rules establish a collaborative process between the Military Services and the Defense Health Agency for notifying the Director, DHA of changes in availability of Active Component uniformed medical and dental personnel on orders to military medical treatment facilities and military dental treatment facilities.

This memorandum distributes the DoD WBH Research Strategy which provides guidance for the DoD research and development activities to coordinate, optimize, and advance warfighter brain health science.

This Defense Health Agency Administrative Instruction establishes the DHA’s procedures to implement standardized and efficient Military Medical Treatment Facility Pharmacy Operations. it endorses standardized and efficient pharmacy operations within MTFs in compliance with TRICARE formulary policy and P&T Committee decisions.

This memorandum provides information and guidance to staff at military medical treatment facilities for implementation of the "2022 Armed Forces Reportable Medical Events Guidelines and Case Definitions".

This memorandum pursuant to section 721 of the National Defense Authorization Act for Fiscal Year 2022 gives instruction to stand four regional centers of excellence with the DHA. The Ocular Trauma Centers are as follows: (1) Brooke Army Medical Center/Wilford Hall Ambulatory Surgical Center; (2) Walter Reed National Military Medical Center/Fort ...

This memorandum the heads of DOD Components to eliminate inaccurate, outdated, or inappropriate language that may contribute to mental health stigma in policy and guidance documents.